EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Enhancing amorphous solid dispersions with alternative excipients: advances in drug formulation, drug-excipient insights, and regulatory landscape

Francisco J T M Tavares, Alexandre J S Ribeiro, Inês I Ramos, Maria C Paisana

European Journal of Pharmaceutics and Biopharmaceutics · 2026-11 · 115297

DOI: 10.1016/j.ejpb.2026.115297 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-11. Verfasst von Francisco J T M Tavares und 3 weiteren Autor:innen. Beteiligte Einrichtung: R&D Analytical Development, Hovione Farmaciência S.A., Campus do Lumiar, Building S, 1649-038 Lisboa, Portugal; R&D Oral Drug Product Development, Ho…. Die Arbeit nennt 304 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poor aqueous solubility remains a major cause of attrition in oral drug development, with amorphous solid dispersions (ASDs) representing one of the most established enabling technologies to overcome this challenge. However, increasingly complex drugs candidates and demands for higher drug loads are stretching the boundaries of current excipient portfolios, driving interest in alternative carrier classes. Accordingly, this review critically examines the use of naturally derived alternative carriers, focusing on polysaccharides, lipids, and proteins in oral ASDs through a systematic literature analysis (2015-2026) comprising 41 excipients and 342 binary solid dispersions. Excipient families were compared in terms of drug loading, amorphization success, drug-excipient interactions, manufacturability, and regulatory considerations. Protein-based carriers spanned the broadest range of APIs, drug loads, and scalable manufacturing conditions, while consistently exhibiting the highest amorphization rates (∼79%), including weak acid, amphoteric, and weak base drugs, and stabilized amorphous APIs drug loads up to 90%. Lipid-based carriers also demonstrated high amorphization rates (∼76%), particularly with neutral compounds, while offering additional solubilization and permeability-enhancing capabilities. In contrast, polysaccharide-based systems revealed limited amorphization success associated with the employed processing techniques (∼35%). Furthermore, alternative excipients were shown to influence dissolution performance through mechanisms including reversible drug-protein interactions, colloidal lipidic species, and digestion-mediated transformations. Beyond direct formulation analysis, this review highlights the importance of regulatory qualification, material standardization, and harmonized performance evaluation methodologies as critical barriers to broader adoption. Collectively, these findings highlight the potential of alternative carriers in expanding the excipient landscape, thus helping to support the next generation of ASD.

Autor:innen und Institutionen

  • R&D Analytical Development, Hovione Farmaciência S.A., Campus do Lumiar, Building S, 1649-038 Lisboa, Portugal; R&D Oral Drug Product Development, Hovione Farmaciência S.A., Campus do Lumiar, Building S, 1649-038 Lisboa…
  • R&D Analytical Development, Hovione Farmaciência S.A., Campus do Lumiar, Building S, 1649-038 Lisboa, Portugal.
  • R&D Oral Drug Product Development, Hovione Farmaciência S.A., Campus do Lumiar, Building S, 1649-038 Lisboa, Portugal.

Förderung

  • Foundation for Science and Technology

Zitieren

APA

Tavares, F. J. T. M., Ribeiro, A. J. S., Ramos, I. I., & Paisana, M. C. (2026). Enhancing amorphous solid dispersions with alternative excipients: advances in drug formulation, drug-excipient insights, and regulatory landscape. European Journal of Pharmaceutics and Biopharmaceutics, 115297. https://doi.org/10.1016/j.ejpb.2026.115297

Vancouver

Tavares FJTM, Ribeiro AJS, Ramos II, Paisana MC. Enhancing amorphous solid dispersions with alternative excipients: advances in drug formulation, drug-excipient insights, and regulatory landscape. European Journal of Pharmaceutics and Biopharmaceutics. 2026:115297. doi:10.1016/j.ejpb.2026.115297

BibTeX
@article{Tavares2026,
  author = {Tavares, Francisco J T M and Ribeiro, Alexandre J S and Ramos, Inês I and Paisana, Maria C},
  title = {Enhancing amorphous solid dispersions with alternative excipients: advances in drug formulation, drug-excipient insights, and regulatory landscape},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  pages = {115297},
  doi = {10.1016/j.ejpb.2026.115297}
}
Kostenlos starten →